4-(2-aminoethyl)benzenesulfonylfluoride has been researched along with Alloxan Diabetes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, HJ | 1 |
Kiew, LV | 1 |
Chin, Y | 1 |
Norazit, A | 1 |
Mohd Noor, S | 1 |
Lo, YL | 1 |
Looi, CY | 1 |
Lau, YS | 1 |
Lim, TM | 1 |
Wong, WF | 1 |
Abdullah, NA | 1 |
Abdul Sattar, MZ | 1 |
Johns, EJ | 1 |
Chik, Z | 1 |
Chung, LY | 1 |
Wang, N | 1 |
Zhang, D | 1 |
Mao, X | 1 |
Zou, F | 1 |
Jin, H | 1 |
Ouyang, J | 1 |
2 other studies available for 4-(2-aminoethyl)benzenesulfonylfluoride and Alloxan Diabetes
Article | Year |
---|---|
Renal targeting potential of a polymeric drug carrier, poly-l-glutamic acid, in normal and diabetic rats.
Topics: Animals; Aorta; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delivery Systems; Epithelial Ce | 2017 |
Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes.
Topics: Activating Transcription Factor 6; Animals; Astragalus Plant; Cell Line; Diabetes Mellitus, Experime | 2009 |